Table: Towa Pharmaceutical -Q1 group results

TOWA PHARMACEUTICAL

10/08/2023 07:01

Aug 10 (Reuters)- 
             Towa Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               54.55               45.37           216.30    
                   (+20.2 pct)         (+5.7 pct)                   
  Operating            4.10                1.84            11.80    
                  (+123.1 pct)         (-69.8 pct)                  
  Recurring            6.96                2.47            11.50    
                  (+181.8 pct)         (-68.0 pct)                  
  Net                  4.75                1.37             6.90    
                  (+245.8 pct)         (-74.1 pct)                  
  EPS               96.51 yen           27.91 yen       140.18 yen  
  EPS Diluted                           27.28 yen                   
  Ann Div                               60.00 yen        60.00 yen  
  -Q2 div                               30.00 yen        30.00 yen  
  -Q4 div                               30.00 yen        30.00 yen  
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T